Melrose, MA, United States of America

Aaron Sather

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 16.7

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: Innovations by Inventor Aaron Sather

Introduction: Aaron Sather, an accomplished inventor based in Melrose, Massachusetts, has made significant contributions to the field of pharmaceutical science. With a total of three patents to his name, Sather's work focuses on the development of novel compounds that address critical health challenges.

Latest Patents: Aaron Sather's latest patents include groundbreaking research on 7-, 8-, and 10-substituted amino triazolo quinazoline derivatives. These compounds are identified as adenosine receptor antagonists, offering potential therapeutic benefits in treating various diseases. The specific embodiments of these inventions provide pharmaceutical compositions that include certain derivatives of Formula (I) or a pharmaceutically acceptable salt thereof. These compositions can be utilized in combination with other therapeutic agents for enhanced efficacy against conditions related to the adenosine A2a and A2b receptors. Additionally, he has patented 9-substituted amino triazolo quinazoline derivatives, further expanding the arsenal of compounds that target these critical receptors.

Career Highlights: Aaron Sather is affiliated with Merck Sharp & Dohme Corporation, a prominent entity in the pharmaceutical industry known for its commitment to innovation and research. His work at Merck places him at the cutting edge of drug development, allowing him to contribute to treatments that can significantly impact patient care.

Collaborations: In his professional journey, Aaron collaborates with several esteemed colleagues, including Matthew A. Larsen and Amjad Ali. These partnerships foster an environment of shared knowledge and innovation, aiding in the advancement of their collective research efforts and contributing to the overall success of their projects.

Conclusion: As a dedicated inventor, Aaron Sather continues to make strides in pharmaceutical research, particularly in the development of adenosine receptor antagonists. His recent patents reflect a commitment to addressing complex medical conditions and improving therapeutic options for patients. With ongoing collaboration and innovative mindset, Sather is poised to leave a lasting impact on the field of pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…